Application | Comment | Organism |
---|---|---|
drug development | nucleoside analog reverse transcriptase inhibitors are capable of affecting complex I activity in a non-polymerase-gamma/mtDNA mediated pathway. Elevations in superoxide produced at complex I caused by nucleoside analog reverse transcriptase inhibitors can provide a mechanism for the oxidative stress observed with these drugs | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2',3'-dideoxycytidine | 0.001 mM prevents the phosphorylation of the NDUFB11 subunit of complex I | Homo sapiens | |
3'-azido-3'-deoxythymidine | 0.01 and 0.05 mM prevent the phosphorylation of the NDUFB11 subunit of complex I. This is associated with a decrease in complex I activity | Homo sapiens | |
3'-azido-3'-deoxythymidine monophosphate | 0.15 mM prevents the phosphorylation of the NDUFB11 subunit of complex I. This is associated with a decrease in complex I activity | Homo sapiens | |
rotenone | - |
Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrion | - |
Homo sapiens | 5739 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Purification (Comment) | Organism |
---|---|
immunocapture-purified | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
Hep-G2 cell | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
complex I | - |
Homo sapiens |
NADH:CoQ1 oxidoreductase | - |
Homo sapiens |